Infection following the implantation of a left ventricular assist device (LVAD) is a life-threatening complication with mortality rates ranging from 15% to 44%. Staphylococcus aureus and Staphylococcus epidermidis are the most frequently identified pathogensand are responsible for 60% of LVAD-related infections, local as well as systemic. In this report we describe the successful therapeutic management of a patient who received a Heart Mate II as "bridging-to-recovery", which was complicated by device infection that was managed without device explantation.

, ,
Hellenic Journal of Cardiology
Department of Cardiology

Gogas, B.D, Parissis, J.T, Iliodromitis, E.K, Tsiodras, S, Radu, M, Paraskevaidis, I.A, … Yacoub, M.H. (2010). Left ventricular assist device vegetation: "Cure" without device explantation. Hellenic Journal of Cardiology, 51(6), 549–551. Retrieved from